nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Epirubicin—pancreatic cancer	0.243	0.38	CbGbCtD
Silodosin—ABCB4—bile duct—pancreatic cancer	0.0841	0.483	CbGeAlD
Silodosin—ABCB4—bile—pancreatic cancer	0.0646	0.372	CbGeAlD
Silodosin—ABCB1—Tamoxifen—pancreatic cancer	0.0528	0.0825	CbGbCtD
Silodosin—ABCB1—Gemcitabine—pancreatic cancer	0.0455	0.0711	CbGbCtD
Silodosin—ABCB1—Erlotinib—pancreatic cancer	0.0449	0.0702	CbGbCtD
Silodosin—ABCB1—Irinotecan—pancreatic cancer	0.0406	0.0634	CbGbCtD
Silodosin—CYP3A4—Tamoxifen—pancreatic cancer	0.0317	0.0494	CbGbCtD
Silodosin—ABCB1—Docetaxel—pancreatic cancer	0.0297	0.0464	CbGbCtD
Silodosin—ABCB1—Sunitinib—pancreatic cancer	0.0296	0.0462	CbGbCtD
Silodosin—CYP3A4—Erlotinib—pancreatic cancer	0.0269	0.042	CbGbCtD
Silodosin—CYP3A4—Irinotecan—pancreatic cancer	0.0243	0.038	CbGbCtD
Silodosin—ABCB1—Doxorubicin—pancreatic cancer	0.0222	0.0346	CbGbCtD
Silodosin—ABCB4—gall bladder—pancreatic cancer	0.0179	0.103	CbGeAlD
Silodosin—CYP3A4—Docetaxel—pancreatic cancer	0.0178	0.0278	CbGbCtD
Silodosin—CYP3A4—Sunitinib—pancreatic cancer	0.0177	0.0277	CbGbCtD
Silodosin—CYP3A4—Doxorubicin—pancreatic cancer	0.0133	0.0207	CbGbCtD
Silodosin—Priapism—Tamoxifen—pancreatic cancer	0.00463	0.0378	CcSEcCtD
Silodosin—UGT2B7—digestive system—pancreatic cancer	0.00361	0.0208	CbGeAlD
Silodosin—Hepatic function abnormal—Tamoxifen—pancreatic cancer	0.00186	0.0152	CcSEcCtD
Silodosin—Hepatic function abnormal—Sunitinib—pancreatic cancer	0.00159	0.013	CcSEcCtD
Silodosin—Nasal congestion—Sunitinib—pancreatic cancer	0.00153	0.0125	CcSEcCtD
Silodosin—Liver function test abnormal—Tamoxifen—pancreatic cancer	0.0015	0.0122	CcSEcCtD
Silodosin—Rhinorrhoea—Docetaxel—pancreatic cancer	0.00135	0.011	CcSEcCtD
Silodosin—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00129	0.0106	CcSEcCtD
Silodosin—Liver function test abnormal—Sunitinib—pancreatic cancer	0.00128	0.0105	CcSEcCtD
Silodosin—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.00128	0.0104	CcSEcCtD
Silodosin—Nasopharyngitis—Sunitinib—pancreatic cancer	0.00124	0.0102	CcSEcCtD
Silodosin—Sinusitis—Tamoxifen—pancreatic cancer	0.00117	0.00959	CcSEcCtD
Silodosin—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.00117	0.00956	CcSEcCtD
Silodosin—ABCB1—islet of Langerhans—pancreatic cancer	0.00116	0.00668	CbGeAlD
Silodosin—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.00105	0.00855	CcSEcCtD
Silodosin—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.00103	0.00842	CcSEcCtD
Silodosin—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.00101	0.00828	CcSEcCtD
Silodosin—Mediastinal disorder—Erlotinib—pancreatic cancer	0.001	0.00818	CcSEcCtD
Silodosin—CYP3A4—digestive system—pancreatic cancer	0.000985	0.00566	CbGeAlD
Silodosin—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.000981	0.00801	CcSEcCtD
Silodosin—Mental disorder—Erlotinib—pancreatic cancer	0.000974	0.00795	CcSEcCtD
Silodosin—Cardiac disorder—Sunitinib—pancreatic cancer	0.000893	0.00729	CcSEcCtD
Silodosin—Angiopathy—Sunitinib—pancreatic cancer	0.000873	0.00713	CcSEcCtD
Silodosin—Immune system disorder—Sunitinib—pancreatic cancer	0.000869	0.0071	CcSEcCtD
Silodosin—Syncope—Erlotinib—pancreatic cancer	0.000868	0.00709	CcSEcCtD
Silodosin—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000867	0.00708	CcSEcCtD
Silodosin—Jaundice—Irinotecan—pancreatic cancer	0.000861	0.00703	CcSEcCtD
Silodosin—Loss of consciousness—Erlotinib—pancreatic cancer	0.000851	0.00695	CcSEcCtD
Silodosin—Mental disorder—Sunitinib—pancreatic cancer	0.000843	0.00688	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000818	0.00668	CcSEcCtD
Silodosin—ABCB1—pancreas—pancreatic cancer	0.000816	0.00469	CbGeAlD
Silodosin—Dry mouth—Tamoxifen—pancreatic cancer	0.000814	0.00665	CcSEcCtD
Silodosin—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000813	0.00664	CcSEcCtD
Silodosin—Sinusitis—Fluorouracil—pancreatic cancer	0.000793	0.00648	CcSEcCtD
Silodosin—Shock—Erlotinib—pancreatic cancer	0.000777	0.00635	CcSEcCtD
Silodosin—Nervous system disorder—Erlotinib—pancreatic cancer	0.000775	0.00632	CcSEcCtD
Silodosin—Skin disorder—Erlotinib—pancreatic cancer	0.000767	0.00626	CcSEcCtD
Silodosin—Cardiac disorder—Irinotecan—pancreatic cancer	0.000736	0.00601	CcSEcCtD
Silodosin—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000731	0.00597	CcSEcCtD
Silodosin—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000723	0.00591	CcSEcCtD
Silodosin—Insomnia—Tamoxifen—pancreatic cancer	0.000722	0.0059	CcSEcCtD
Silodosin—Angiopathy—Irinotecan—pancreatic cancer	0.000719	0.00587	CcSEcCtD
Silodosin—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000717	0.00585	CcSEcCtD
Silodosin—Immune system disorder—Irinotecan—pancreatic cancer	0.000716	0.00585	CcSEcCtD
Silodosin—Breast disorder—Docetaxel—pancreatic cancer	0.000716	0.00585	CcSEcCtD
Silodosin—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000714	0.00583	CcSEcCtD
Silodosin—Insomnia—Erlotinib—pancreatic cancer	0.000714	0.00583	CcSEcCtD
Silodosin—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000708	0.00578	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000708	0.00578	CcSEcCtD
Silodosin—Angiopathy—Gemcitabine—pancreatic cancer	0.000701	0.00572	CcSEcCtD
Silodosin—Dry mouth—Sunitinib—pancreatic cancer	0.000697	0.0057	CcSEcCtD
Silodosin—Immune system disorder—Gemcitabine—pancreatic cancer	0.000697	0.0057	CcSEcCtD
Silodosin—ABCB1—digestive system—pancreatic cancer	0.000697	0.00401	CbGeAlD
Silodosin—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000696	0.00568	CcSEcCtD
Silodosin—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000689	0.00563	CcSEcCtD
Silodosin—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000682	0.00557	CcSEcCtD
Silodosin—Shock—Sunitinib—pancreatic cancer	0.000673	0.00549	CcSEcCtD
Silodosin—Nervous system disorder—Sunitinib—pancreatic cancer	0.00067	0.00548	CcSEcCtD
Silodosin—Skin disorder—Sunitinib—pancreatic cancer	0.000664	0.00542	CcSEcCtD
Silodosin—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000653	0.00533	CcSEcCtD
Silodosin—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000646	0.00527	CcSEcCtD
Silodosin—Urticaria—Tamoxifen—pancreatic cancer	0.000634	0.00518	CcSEcCtD
Silodosin—Abdominal pain—Tamoxifen—pancreatic cancer	0.000631	0.00515	CcSEcCtD
Silodosin—Abdominal pain—Erlotinib—pancreatic cancer	0.000624	0.0051	CcSEcCtD
Silodosin—Syncope—Irinotecan—pancreatic cancer	0.000619	0.00505	CcSEcCtD
Silodosin—Insomnia—Sunitinib—pancreatic cancer	0.000618	0.00505	CcSEcCtD
Silodosin—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000611	0.00499	CcSEcCtD
Silodosin—Loss of consciousness—Irinotecan—pancreatic cancer	0.000606	0.00495	CcSEcCtD
Silodosin—Vascular purpura—Epirubicin—pancreatic cancer	0.000597	0.00488	CcSEcCtD
Silodosin—Jaundice—Docetaxel—pancreatic cancer	0.000595	0.00486	CcSEcCtD
Silodosin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00059	0.00482	CcSEcCtD
Silodosin—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000577	0.00471	CcSEcCtD
Silodosin—Asthenia—Tamoxifen—pancreatic cancer	0.000573	0.00468	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000568	0.00464	CcSEcCtD
Silodosin—Asthenia—Erlotinib—pancreatic cancer	0.000567	0.00463	CcSEcCtD
Silodosin—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000566	0.00462	CcSEcCtD
Silodosin—Pruritus—Tamoxifen—pancreatic cancer	0.000565	0.00461	CcSEcCtD
Silodosin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000559	0.00457	CcSEcCtD
Silodosin—Pruritus—Erlotinib—pancreatic cancer	0.000559	0.00456	CcSEcCtD
Silodosin—Purpura—Epirubicin—pancreatic cancer	0.000554	0.00453	CcSEcCtD
Silodosin—Shock—Irinotecan—pancreatic cancer	0.000554	0.00452	CcSEcCtD
Silodosin—Vascular purpura—Doxorubicin—pancreatic cancer	0.000553	0.00451	CcSEcCtD
Silodosin—Nervous system disorder—Irinotecan—pancreatic cancer	0.000552	0.00451	CcSEcCtD
Silodosin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000546	0.00446	CcSEcCtD
Silodosin—Abdominal pain—Sunitinib—pancreatic cancer	0.00054	0.00441	CcSEcCtD
Silodosin—Diarrhoea—Erlotinib—pancreatic cancer	0.00054	0.00441	CcSEcCtD
Silodosin—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000538	0.00439	CcSEcCtD
Silodosin—Skin disorder—Gemcitabine—pancreatic cancer	0.000533	0.00435	CcSEcCtD
Silodosin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000529	0.00432	CcSEcCtD
Silodosin—Dizziness—Tamoxifen—pancreatic cancer	0.000528	0.00431	CcSEcCtD
Silodosin—Tachycardia—Fluorouracil—pancreatic cancer	0.000526	0.0043	CcSEcCtD
Silodosin—Hypotension—Irinotecan—pancreatic cancer	0.000526	0.0043	CcSEcCtD
Silodosin—Dizziness—Erlotinib—pancreatic cancer	0.000522	0.00426	CcSEcCtD
Silodosin—Purpura—Doxorubicin—pancreatic cancer	0.000513	0.00419	CcSEcCtD
Silodosin—Hypotension—Gemcitabine—pancreatic cancer	0.000513	0.00419	CcSEcCtD
Silodosin—Insomnia—Irinotecan—pancreatic cancer	0.000509	0.00416	CcSEcCtD
Silodosin—Cardiac disorder—Docetaxel—pancreatic cancer	0.000509	0.00415	CcSEcCtD
Silodosin—Hypotension—Fluorouracil—pancreatic cancer	0.000504	0.00412	CcSEcCtD
Silodosin—Rash—Tamoxifen—pancreatic cancer	0.000503	0.00411	CcSEcCtD
Silodosin—Dermatitis—Tamoxifen—pancreatic cancer	0.000503	0.00411	CcSEcCtD
Silodosin—Headache—Tamoxifen—pancreatic cancer	0.0005	0.00408	CcSEcCtD
Silodosin—Rash—Erlotinib—pancreatic cancer	0.000498	0.00407	CcSEcCtD
Silodosin—Dermatitis—Erlotinib—pancreatic cancer	0.000498	0.00406	CcSEcCtD
Silodosin—Angiopathy—Docetaxel—pancreatic cancer	0.000497	0.00406	CcSEcCtD
Silodosin—Insomnia—Gemcitabine—pancreatic cancer	0.000496	0.00405	CcSEcCtD
Silodosin—Immune system disorder—Docetaxel—pancreatic cancer	0.000495	0.00404	CcSEcCtD
Silodosin—Headache—Erlotinib—pancreatic cancer	0.000495	0.00404	CcSEcCtD
Silodosin—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000494	0.00403	CcSEcCtD
Silodosin—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000493	0.00403	CcSEcCtD
Silodosin—Asthenia—Sunitinib—pancreatic cancer	0.000491	0.00401	CcSEcCtD
Silodosin—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000488	0.00398	CcSEcCtD
Silodosin—Insomnia—Fluorouracil—pancreatic cancer	0.000488	0.00398	CcSEcCtD
Silodosin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000486	0.00397	CcSEcCtD
Silodosin—Pruritus—Sunitinib—pancreatic cancer	0.000484	0.00395	CcSEcCtD
Silodosin—Breast disorder—Epirubicin—pancreatic cancer	0.000483	0.00394	CcSEcCtD
Silodosin—Mental disorder—Docetaxel—pancreatic cancer	0.00048	0.00392	CcSEcCtD
Silodosin—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000478	0.0039	CcSEcCtD
Silodosin—Nausea—Tamoxifen—pancreatic cancer	0.000474	0.00387	CcSEcCtD
Silodosin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000474	0.00387	CcSEcCtD
Silodosin—Nausea—Erlotinib—pancreatic cancer	0.000469	0.00383	CcSEcCtD
Silodosin—Diarrhoea—Sunitinib—pancreatic cancer	0.000468	0.00382	CcSEcCtD
Silodosin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000466	0.0038	CcSEcCtD
Silodosin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000461	0.00376	CcSEcCtD
Silodosin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000456	0.00373	CcSEcCtD
Silodosin—Dizziness—Sunitinib—pancreatic cancer	0.000452	0.00369	CcSEcCtD
Silodosin—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000451	0.00369	CcSEcCtD
Silodosin—Breast disorder—Doxorubicin—pancreatic cancer	0.000447	0.00365	CcSEcCtD
Silodosin—Abdominal pain—Irinotecan—pancreatic cancer	0.000445	0.00364	CcSEcCtD
Silodosin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000442	0.00361	CcSEcCtD
Silodosin—Rash—Sunitinib—pancreatic cancer	0.000431	0.00352	CcSEcCtD
Silodosin—Dermatitis—Sunitinib—pancreatic cancer	0.000431	0.00352	CcSEcCtD
Silodosin—Urticaria—Fluorouracil—pancreatic cancer	0.000428	0.0035	CcSEcCtD
Silodosin—Headache—Sunitinib—pancreatic cancer	0.000428	0.0035	CcSEcCtD
Silodosin—Syncope—Docetaxel—pancreatic cancer	0.000428	0.00349	CcSEcCtD
Silodosin—Palpitations—Docetaxel—pancreatic cancer	0.000422	0.00344	CcSEcCtD
Silodosin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000419	0.00342	CcSEcCtD
Silodosin—Nausea—Sunitinib—pancreatic cancer	0.000406	0.00332	CcSEcCtD
Silodosin—Asthenia—Irinotecan—pancreatic cancer	0.000404	0.0033	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000403	0.00329	CcSEcCtD
Silodosin—Jaundice—Epirubicin—pancreatic cancer	0.000401	0.00328	CcSEcCtD
Silodosin—Dry mouth—Docetaxel—pancreatic cancer	0.000397	0.00324	CcSEcCtD
Silodosin—Asthenia—Gemcitabine—pancreatic cancer	0.000394	0.00321	CcSEcCtD
Silodosin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000389	0.00318	CcSEcCtD
Silodosin—Pruritus—Gemcitabine—pancreatic cancer	0.000388	0.00317	CcSEcCtD
Silodosin—Sinusitis—Epirubicin—pancreatic cancer	0.000386	0.00315	CcSEcCtD
Silodosin—Diarrhoea—Irinotecan—pancreatic cancer	0.000385	0.00315	CcSEcCtD
Silodosin—Shock—Docetaxel—pancreatic cancer	0.000383	0.00313	CcSEcCtD
Silodosin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000382	0.00312	CcSEcCtD
Silodosin—Pruritus—Fluorouracil—pancreatic cancer	0.000382	0.00312	CcSEcCtD
Silodosin—Tachycardia—Docetaxel—pancreatic cancer	0.00038	0.0031	CcSEcCtD
Silodosin—Skin disorder—Docetaxel—pancreatic cancer	0.000378	0.00309	CcSEcCtD
Silodosin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000375	0.00307	CcSEcCtD
Silodosin—Dizziness—Irinotecan—pancreatic cancer	0.000372	0.00304	CcSEcCtD
Silodosin—Jaundice—Doxorubicin—pancreatic cancer	0.000371	0.00303	CcSEcCtD
Silodosin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000369	0.00301	CcSEcCtD
Silodosin—Hypotension—Docetaxel—pancreatic cancer	0.000364	0.00297	CcSEcCtD
Silodosin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00036	0.00294	CcSEcCtD
Silodosin—Sinusitis—Doxorubicin—pancreatic cancer	0.000357	0.00292	CcSEcCtD
Silodosin—Dizziness—Fluorouracil—pancreatic cancer	0.000357	0.00291	CcSEcCtD
Silodosin—Rash—Irinotecan—pancreatic cancer	0.000355	0.0029	CcSEcCtD
Silodosin—Dermatitis—Irinotecan—pancreatic cancer	0.000355	0.0029	CcSEcCtD
Silodosin—Headache—Irinotecan—pancreatic cancer	0.000353	0.00288	CcSEcCtD
Silodosin—Insomnia—Docetaxel—pancreatic cancer	0.000352	0.00288	CcSEcCtD
Silodosin—Rash—Gemcitabine—pancreatic cancer	0.000346	0.00282	CcSEcCtD
Silodosin—Dermatitis—Gemcitabine—pancreatic cancer	0.000346	0.00282	CcSEcCtD
Silodosin—Headache—Gemcitabine—pancreatic cancer	0.000344	0.00281	CcSEcCtD
Silodosin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000343	0.0028	CcSEcCtD
Silodosin—Rash—Fluorouracil—pancreatic cancer	0.00034	0.00278	CcSEcCtD
Silodosin—Dermatitis—Fluorouracil—pancreatic cancer	0.00034	0.00277	CcSEcCtD
Silodosin—Headache—Fluorouracil—pancreatic cancer	0.000338	0.00276	CcSEcCtD
Silodosin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000336	0.00274	CcSEcCtD
Silodosin—Angiopathy—Epirubicin—pancreatic cancer	0.000335	0.00274	CcSEcCtD
Silodosin—Nausea—Irinotecan—pancreatic cancer	0.000335	0.00273	CcSEcCtD
Silodosin—Immune system disorder—Epirubicin—pancreatic cancer	0.000334	0.00273	CcSEcCtD
Silodosin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000333	0.00272	CcSEcCtD
Silodosin—Nausea—Gemcitabine—pancreatic cancer	0.000326	0.00266	CcSEcCtD
Silodosin—Mental disorder—Epirubicin—pancreatic cancer	0.000324	0.00264	CcSEcCtD
Silodosin—Nausea—Fluorouracil—pancreatic cancer	0.00032	0.00262	CcSEcCtD
Silodosin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000318	0.0026	CcSEcCtD
Silodosin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000317	0.00259	CcSEcCtD
Silodosin—Angiopathy—Doxorubicin—pancreatic cancer	0.00031	0.00253	CcSEcCtD
Silodosin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000309	0.00252	CcSEcCtD
Silodosin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000308	0.00252	CcSEcCtD
Silodosin—Abdominal pain—Docetaxel—pancreatic cancer	0.000308	0.00251	CcSEcCtD
Silodosin—Mental disorder—Doxorubicin—pancreatic cancer	0.0003	0.00245	CcSEcCtD
Silodosin—Syncope—Epirubicin—pancreatic cancer	0.000289	0.00236	CcSEcCtD
Silodosin—Palpitations—Epirubicin—pancreatic cancer	0.000284	0.00232	CcSEcCtD
Silodosin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000283	0.00231	CcSEcCtD
Silodosin—Asthenia—Docetaxel—pancreatic cancer	0.000279	0.00228	CcSEcCtD
Silodosin—Pruritus—Docetaxel—pancreatic cancer	0.000275	0.00225	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000272	0.00222	CcSEcCtD
Silodosin—Dry mouth—Epirubicin—pancreatic cancer	0.000268	0.00219	CcSEcCtD
Silodosin—Syncope—Doxorubicin—pancreatic cancer	0.000267	0.00218	CcSEcCtD
Silodosin—Diarrhoea—Docetaxel—pancreatic cancer	0.000266	0.00218	CcSEcCtD
Silodosin—Palpitations—Doxorubicin—pancreatic cancer	0.000263	0.00215	CcSEcCtD
Silodosin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000262	0.00214	CcSEcCtD
Silodosin—Shock—Epirubicin—pancreatic cancer	0.000258	0.00211	CcSEcCtD
Silodosin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000258	0.0021	CcSEcCtD
Silodosin—Dizziness—Docetaxel—pancreatic cancer	0.000257	0.0021	CcSEcCtD
Silodosin—Tachycardia—Epirubicin—pancreatic cancer	0.000256	0.00209	CcSEcCtD
Silodosin—Skin disorder—Epirubicin—pancreatic cancer	0.000255	0.00208	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000252	0.00206	CcSEcCtD
Silodosin—Dry mouth—Doxorubicin—pancreatic cancer	0.000248	0.00202	CcSEcCtD
Silodosin—Rash—Docetaxel—pancreatic cancer	0.000245	0.002	CcSEcCtD
Silodosin—Hypotension—Epirubicin—pancreatic cancer	0.000245	0.002	CcSEcCtD
Silodosin—Dermatitis—Docetaxel—pancreatic cancer	0.000245	0.002	CcSEcCtD
Silodosin—Headache—Docetaxel—pancreatic cancer	0.000244	0.00199	CcSEcCtD
Silodosin—Shock—Doxorubicin—pancreatic cancer	0.000239	0.00195	CcSEcCtD
Silodosin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000238	0.00195	CcSEcCtD
Silodosin—Insomnia—Epirubicin—pancreatic cancer	0.000237	0.00194	CcSEcCtD
Silodosin—Tachycardia—Doxorubicin—pancreatic cancer	0.000237	0.00194	CcSEcCtD
Silodosin—Skin disorder—Doxorubicin—pancreatic cancer	0.000236	0.00193	CcSEcCtD
Silodosin—Nausea—Docetaxel—pancreatic cancer	0.000231	0.00189	CcSEcCtD
Silodosin—Hypotension—Doxorubicin—pancreatic cancer	0.000227	0.00185	CcSEcCtD
Silodosin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000227	0.00185	CcSEcCtD
Silodosin—Insomnia—Doxorubicin—pancreatic cancer	0.00022	0.00179	CcSEcCtD
Silodosin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000215	0.00175	CcSEcCtD
Silodosin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00021	0.00171	CcSEcCtD
Silodosin—Urticaria—Epirubicin—pancreatic cancer	0.000209	0.0017	CcSEcCtD
Silodosin—Abdominal pain—Epirubicin—pancreatic cancer	0.000208	0.0017	CcSEcCtD
Silodosin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000199	0.00162	CcSEcCtD
Silodosin—Urticaria—Doxorubicin—pancreatic cancer	0.000193	0.00158	CcSEcCtD
Silodosin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000192	0.00157	CcSEcCtD
Silodosin—Asthenia—Epirubicin—pancreatic cancer	0.000188	0.00154	CcSEcCtD
Silodosin—Pruritus—Epirubicin—pancreatic cancer	0.000186	0.00152	CcSEcCtD
Silodosin—Diarrhoea—Epirubicin—pancreatic cancer	0.00018	0.00147	CcSEcCtD
Silodosin—Asthenia—Doxorubicin—pancreatic cancer	0.000174	0.00142	CcSEcCtD
Silodosin—Dizziness—Epirubicin—pancreatic cancer	0.000174	0.00142	CcSEcCtD
Silodosin—Pruritus—Doxorubicin—pancreatic cancer	0.000172	0.0014	CcSEcCtD
Silodosin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000166	0.00136	CcSEcCtD
Silodosin—Rash—Epirubicin—pancreatic cancer	0.000166	0.00135	CcSEcCtD
Silodosin—Dermatitis—Epirubicin—pancreatic cancer	0.000165	0.00135	CcSEcCtD
Silodosin—Headache—Epirubicin—pancreatic cancer	0.000164	0.00134	CcSEcCtD
Silodosin—Dizziness—Doxorubicin—pancreatic cancer	0.000161	0.00131	CcSEcCtD
Silodosin—Nausea—Epirubicin—pancreatic cancer	0.000156	0.00127	CcSEcCtD
Silodosin—Rash—Doxorubicin—pancreatic cancer	0.000153	0.00125	CcSEcCtD
Silodosin—Dermatitis—Doxorubicin—pancreatic cancer	0.000153	0.00125	CcSEcCtD
Silodosin—Headache—Doxorubicin—pancreatic cancer	0.000152	0.00124	CcSEcCtD
Silodosin—Nausea—Doxorubicin—pancreatic cancer	0.000144	0.00118	CcSEcCtD
Silodosin—ABCB4—Metabolism—PIK3CA—pancreatic cancer	3.51e-05	0.000556	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	3.47e-05	0.00055	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CNR2—pancreatic cancer	3.44e-05	0.000546	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GLP1R—pancreatic cancer	3.44e-05	0.000546	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.44e-05	0.000546	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CXCL8—pancreatic cancer	3.44e-05	0.000545	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	3.44e-05	0.000545	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	3.42e-05	0.000543	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCKAR—pancreatic cancer	3.39e-05	0.000537	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ARG2—pancreatic cancer	3.33e-05	0.000529	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	3.29e-05	0.000521	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	3.29e-05	0.000521	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JAG2—pancreatic cancer	3.28e-05	0.000521	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MEN1—pancreatic cancer	3.24e-05	0.000513	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SST—pancreatic cancer	3.23e-05	0.000511	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.19e-05	0.000506	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.18e-05	0.000504	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	3.18e-05	0.000504	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—JAG1—pancreatic cancer	3.16e-05	0.0005	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOTCH3—pancreatic cancer	3.14e-05	0.000498	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	3.14e-05	0.000497	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.11e-05	0.000493	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SHH—pancreatic cancer	3.09e-05	0.000489	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOTCH4—pancreatic cancer	3.07e-05	0.000486	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	3.06e-05	0.000485	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	3.06e-05	0.000485	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	3.06e-05	0.000484	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IAPP—pancreatic cancer	3.05e-05	0.000483	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	3.01e-05	0.000477	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CNR1—pancreatic cancer	2.98e-05	0.000472	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTHLH—pancreatic cancer	2.93e-05	0.000464	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTCH1—pancreatic cancer	2.93e-05	0.000464	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	2.92e-05	0.000462	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TYMP—pancreatic cancer	2.91e-05	0.000462	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CG—pancreatic cancer	2.89e-05	0.000458	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	2.87e-05	0.000456	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GCG—pancreatic cancer	2.87e-05	0.000456	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—APOE—pancreatic cancer	2.87e-05	0.000455	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—AKT1—pancreatic cancer	2.87e-05	0.000454	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.86e-05	0.000453	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.85e-05	0.000452	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.8e-05	0.000443	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.8e-05	0.000443	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	2.74e-05	0.000435	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGTR1—pancreatic cancer	2.74e-05	0.000435	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	2.73e-05	0.000432	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	2.71e-05	0.000429	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STK11—pancreatic cancer	2.7e-05	0.000428	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SST—pancreatic cancer	2.68e-05	0.000424	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.66e-05	0.000422	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.64e-05	0.000419	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.64e-05	0.000419	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—JAG1—pancreatic cancer	2.62e-05	0.000415	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOTCH3—pancreatic cancer	2.61e-05	0.000414	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	2.6e-05	0.000412	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	2.6e-05	0.000412	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	2.59e-05	0.000411	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CD—pancreatic cancer	2.54e-05	0.000403	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PPARG—pancreatic cancer	2.5e-05	0.000397	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CNR1—pancreatic cancer	2.47e-05	0.000392	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.44e-05	0.000386	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.43e-05	0.000385	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CG—pancreatic cancer	2.4e-05	0.00038	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GCG—pancreatic cancer	2.39e-05	0.000378	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SST—pancreatic cancer	2.38e-05	0.000377	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.37e-05	0.000376	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SMAD4—pancreatic cancer	2.37e-05	0.000375	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.35e-05	0.000372	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.35e-05	0.000372	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.35e-05	0.000372	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CXCL8—pancreatic cancer	2.34e-05	0.000371	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	2.33e-05	0.000369	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.32e-05	0.000368	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	2.32e-05	0.000367	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HES1—pancreatic cancer	2.31e-05	0.000366	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—DPYD—pancreatic cancer	2.31e-05	0.000366	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	2.28e-05	0.000361	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGTR1—pancreatic cancer	2.28e-05	0.000361	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STK11—pancreatic cancer	2.24e-05	0.000356	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CB—pancreatic cancer	2.21e-05	0.000351	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	2.19e-05	0.000348	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.19e-05	0.000348	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	2.13e-05	0.000338	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CXCL8—pancreatic cancer	2.13e-05	0.000337	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	2.12e-05	0.000336	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CD—pancreatic cancer	2.11e-05	0.000334	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.06e-05	0.000327	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.05e-05	0.000326	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TERT—pancreatic cancer	2.03e-05	0.000321	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.02e-05	0.000321	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	2.02e-05	0.00032	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	1.99e-05	0.000316	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	1.99e-05	0.000315	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.98e-05	0.000314	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—pancreatic cancer	1.97e-05	0.000312	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SMAD4—pancreatic cancer	1.96e-05	0.000311	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCL8—pancreatic cancer	1.94e-05	0.000308	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HIF1A—pancreatic cancer	1.94e-05	0.000307	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TSC2—pancreatic cancer	1.93e-05	0.000306	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HES1—pancreatic cancer	1.92e-05	0.000304	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOE—pancreatic cancer	1.89e-05	0.0003	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.87e-05	0.000297	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KDR—pancreatic cancer	1.85e-05	0.000294	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CB—pancreatic cancer	1.84e-05	0.000291	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.8e-05	0.000285	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.8e-05	0.000285	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCL8—pancreatic cancer	1.77e-05	0.00028	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NFKBIA—pancreatic cancer	1.76e-05	0.000279	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	1.75e-05	0.000277	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOTCH1—pancreatic cancer	1.75e-05	0.000277	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.73e-05	0.000274	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTEN—pancreatic cancer	1.72e-05	0.000272	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CG—pancreatic cancer	1.71e-05	0.00027	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—NRAS—pancreatic cancer	1.71e-05	0.00027	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	1.7e-05	0.00027	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CD44—pancreatic cancer	1.7e-05	0.000269	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGF—pancreatic cancer	1.69e-05	0.000267	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TERT—pancreatic cancer	1.68e-05	0.000266	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.63e-05	0.000259	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GCG—pancreatic cancer	1.63e-05	0.000258	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HIF1A—pancreatic cancer	1.61e-05	0.000255	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TSC2—pancreatic cancer	1.6e-05	0.000254	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOE—pancreatic cancer	1.57e-05	0.000249	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	1.57e-05	0.000249	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—pancreatic cancer	1.55e-05	0.000246	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KDR—pancreatic cancer	1.54e-05	0.000244	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—STK11—pancreatic cancer	1.53e-05	0.000243	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CD—pancreatic cancer	1.5e-05	0.000238	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	1.49e-05	0.000237	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.49e-05	0.000236	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—KRAS—pancreatic cancer	1.47e-05	0.000233	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	1.46e-05	0.000232	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	1.45e-05	0.00023	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.45e-05	0.000229	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	1.43e-05	0.000226	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	1.42e-05	0.000226	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.42e-05	0.000226	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	1.42e-05	0.000225	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	1.42e-05	0.000225	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	1.4e-05	0.000222	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	1.39e-05	0.000221	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	1.37e-05	0.000216	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.35e-05	0.000214	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CA—pancreatic cancer	1.35e-05	0.000214	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TYMS—pancreatic cancer	1.32e-05	0.000209	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	1.31e-05	0.000207	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.3e-05	0.000206	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	1.29e-05	0.000205	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.29e-05	0.000204	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.26e-05	0.000199	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	1.26e-05	0.000199	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	1.26e-05	0.000199	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	1.25e-05	0.000198	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	1.25e-05	0.000197	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	1.24e-05	0.000197	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.23e-05	0.000195	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	1.22e-05	0.000193	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	1.21e-05	0.000192	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	1.21e-05	0.000192	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	1.2e-05	0.000191	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	1.17e-05	0.000186	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	1.16e-05	0.000184	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	1.15e-05	0.000182	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	1.14e-05	0.00018	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	1.13e-05	0.000179	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.12e-05	0.000178	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.11e-05	0.000175	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	1.1e-05	0.000175	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.1e-05	0.000174	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	1.09e-05	0.000172	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	1.08e-05	0.000172	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOE—pancreatic cancer	1.07e-05	0.00017	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	1.05e-05	0.000166	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CD44—pancreatic cancer	1.05e-05	0.000166	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	1.04e-05	0.000165	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	1.04e-05	0.000164	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	1.02e-05	0.000162	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	1.01e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	1.01e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	1.01e-05	0.00016	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCG—pancreatic cancer	1e-05	0.000159	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	9.98e-06	0.000158	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	9.95e-06	0.000158	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—pancreatic cancer	9.9e-06	0.000157	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	9.72e-06	0.000154	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	9.67e-06	0.000153	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	9.64e-06	0.000153	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	9.62e-06	0.000153	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	9.43e-06	0.00015	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—STK11—pancreatic cancer	9.43e-06	0.00015	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	9.39e-06	0.000149	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	9.38e-06	0.000149	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	9.37e-06	0.000148	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—pancreatic cancer	9.33e-06	0.000148	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	9.26e-06	0.000147	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	9.2e-06	0.000146	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	9.18e-06	0.000146	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	9.15e-06	0.000145	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	8.95e-06	0.000142	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	8.87e-06	0.000141	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	8.7e-06	0.000138	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	8.68e-06	0.000138	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	8.63e-06	0.000137	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	8.55e-06	0.000135	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	8.5e-06	0.000135	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	8.47e-06	0.000134	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	8.39e-06	0.000133	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	8.38e-06	0.000133	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	8.37e-06	0.000133	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	8.33e-06	0.000132	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	8.13e-06	0.000129	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TYMS—pancreatic cancer	8.11e-06	0.000129	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	7.97e-06	0.000126	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	7.79e-06	0.000124	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	7.77e-06	0.000123	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	7.73e-06	0.000122	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	7.71e-06	0.000122	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	7.62e-06	0.000121	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	7.52e-06	0.000119	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	7.45e-06	0.000118	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	7.43e-06	0.000118	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	7.41e-06	0.000117	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	7.38e-06	0.000117	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—pancreatic cancer	7.34e-06	0.000116	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	7.2e-06	0.000114	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	6.92e-06	0.00011	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	6.91e-06	0.000109	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	6.77e-06	0.000107	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	6.62e-06	0.000105	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOE—pancreatic cancer	6.6e-06	0.000105	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	6.51e-06	0.000103	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTEN—pancreatic cancer	6.4e-06	0.000101	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	6.4e-06	0.000101	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	6.4e-06	0.000101	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	6.12e-06	9.7e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.96e-06	9.44e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	5.88e-06	9.31e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.75e-06	9.11e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	5.69e-06	9.01e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	5.44e-06	8.62e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	5.4e-06	8.57e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.24e-06	8.3e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	4.8e-06	7.61e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.56e-06	7.23e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.52e-06	7.17e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4.52e-06	7.16e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.94e-06	6.25e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—pancreatic cancer	3.69e-06	5.85e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.78e-06	4.41e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.27e-06	3.6e-05	CbGpPWpGaD
